Search Results
359 results found-
There are a lot of important things to think about before deciding to participate in a trial.
https://www.csl.com/research-and-development/clinical-studies/how-to-participate -
Answers to the most frequently asked questions about Clinical Trials.
https://www.csl.com/research-and-development/clinical-studies/clinical-studies-faqs -
CSL's clinical trials are one of the most important steps in the years-long process of obtaining approval for new medications.
https://www.csl.com/research-and-development/clinical-studies -
CSL conducts clinical trials on all of its products. See if one of our current clinical trials might be right for you.
https://www.csl.com/research-and-development/clinical-studies/current-clinical-trials -
CSL conducts clinical trials in accordance with our Code of Responsible Business Practice and the current Guideline for Good Clinical Practice (GCP) of the International Conference on Harmonization (ICH).
https://www.csl.com/research-and-development/clinical-studies/research-practices -
Clinical Trials Day Is May 20. Follow the journey of a potential treatment through four important phases.
https://www.csl.com/we-are-csl/vita-original-stories/2023/infographic-what-is-a-clinical-trial -
Thanks to patient advisory boards, CSL is continuously learning how to partner with patients and make clinical trials less burdensome.
https://www.csl.com/we-are-csl/vita-original-stories/2024/5-ways-were-making-clinical-trials-better-for-patients-and-care-partners -
CSL and CliniSpan Health partnered on a large-scale survey in 2023 to better understand generational differences related to health care experiences. This research project offers insights to make clinical trials and education more accessible to this under-represented population.
https://www.csl.com/we-are-csl/vita-original-stories/2024/increasing-equity-in-health-care-access-and-clinical-trial-participation-among-african-americans -
Sparsentan was well-tolerated with a consistent safety profile across all clinical trials conducted to date and comparable to irbesartan
https://newsroom.csl.com/2023-05-02-Topline-Results-from-Two-Year-Primary-Efficacy-Endpoint-in-Pivotal-Phase-3-DUPLEX-Study-of-Sparsentan-in-Focal-Segmental-Glomerulosclerosis -
QURE), and sponsorship of the clinical trials transitioned to CSL after it acquired global rights to commercialize the treatment. "
https://newsroom.csl.com/2022-11-22-U-S-Food-and-Drug-Administration-approves-CSLs-HEMGENIX-R-etranacogene-dezaparvovec-drlb-,-the-first-gene-therapy-for-hemophilia-B